OUR BLOG
Latest Updates & News
At vero eos et accusamus iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos at dolores molestias excepturi sint occaecati cupiditate.
Running Vaccine Trials in Africa: What You Need to Know
Learn about about what it truly takes to run vaccine trials in Africa today in this podcast episode
How to Design Phase I Vaccine Studies in Europe Webinar
The How to Design Phase I Vaccine Studies in Europe Webinar is a focused session for sponsors and biotech leaders...
Origins, Growth & Evidence Strategy in Infectious Disease Research
Contagious Thinking Podcast Episode One: Origins, Growth & Evidence Strategy in Infectious Disease Research with P95 CEO Thomas
Expanding with Purpose: P95 Opens New Offices in Ghana and Kenya to Strengthen Vaccine Research Across Africa
In April 2025, P95 proudly opened two new offices on the African continent, in Kenya and Ghana, reinforcing regional impact and collaboration
Pharmacovigilance support in global clinical trials: insights from the CPIVC webinar
P95 shares pharmacovigilance support in global clinical trials through key regulatory insights presented at the CPIVC webinar
Advancing Vaccine Research at World Vaccine Congress Washington 2025
As World Vaccine Congress Washington 2025 comes to a close, we reflect on an impactful three days of collaboration,...
P95 and LatinaBA enter a strategic partnership to propel vaccine research in Latin America
P95 and LatinaBA are pleased to announce their strategic partnership, aimed at propelling vaccine and infectious disease research in Latin America.
COVID-19 vaccine effectiveness study against JN.1 variant using id.DRIVE platform
Background Prior studies have reported lower effectiveness of XBB.1.5-adapted vaccines against hospitalization related...
Protocol development: Observational study EAGLE
Abstract Background: Immunocompromised individuals are known to respond inadequately to SARS-CoV-2 vaccines, placing...
Qualitative study on COVID-19 avoidance behavior after lockdown
Abstract Background: This exploratory qualitative study involved semi-structured interviews with adults and caregivers...
P95 At Vaccine World Asia Congress
P95 successfully exhibited at the Vaccine World Asia Congress 2024, held on 6-7 November in Bangkok, Thailand. The...
P95 At World Vaccine Congress Europe 2024
This October, the P95 team attended and exhibited at Europe's largest vaccine event, the World Vaccine Congress Europe...
P95 Webinar Explores Insights to Conducting Clinical Trials in Africa
Join P95 for its webinar on Insights to conducting clinical trials in Africa, on 5 November.
Systematic Literature Review: Effect of pneumococcal conjugate vaccines on viral respiratory infections
In addition to preventing pneumococcal disease, emerging evidence indicates that pneumococcal conjugate vaccines (PCVs) might indirectly reduce viral respiratory tract infections (RTIs) by affecting pneumococcal-viral interactions.
P95 Acquires Assign DMB, Expanding Data Management and Biostatistics Services
P95, a leading global provider of epidemiology and clinical solutions with a specialty focus on vaccines and infectious diseases, is excited to announce the acquisition of Assign DMB.
P95 Transforming Exercise into Charitable Impact
At P95, we believe in the power of movement – not just as a means to personal health, but as a catalyst for global change. Our Strava group, an initiative that promotes health and fitness within the team, has successfully translated the time logged over the last year into substantial donations for three charities that make a real difference.
Laurence De Moerlooze Joins P95 as Chief Medical Officer
P95 BV, an Ampersand Capital Partners portfolio company, is proud to announce the appointment of Laurence De Moerlooze as Chief Medical Officer (CMO).
P95 Acquires 4Clinics to Expand Global CRO Services, Strengthen Position as Market Leader
P95 BV, is excited to announce the strategic acquisition of 4Clinics, a Contract Research Organization providing Data Management, Biostatistics, Scientific Writing, Regulatory Affairs and Clinical Operations services for clinical and epidemiological studies.
Celebrating P95’s Anniversary: From our Humble Beginnings to a Global Full-Service CRO
As we approach our 13th anniversary on June 16, we pause to celebrate important milestones and extend our deepest gratitude to our staff, partners and clients who have been part of our growth journey!
P95 Expands its Global Presence with a New USA Office
P95 has opened its first office in the USA. Based in the Research Triangle Park in North Carolina, the largest research park in the USA, this expansion underlines P95s commitment to delivering high-quality research solutions to our clients and partners across the globe.